Previous close | 3.5500 |
Open | 0.0000 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.0000 - 0.0000 |
52-week range | |
Volume | |
Avg. volume | 2,341 |
Market cap | 1.643M |
Beta (5Y monthly) | 0.88 |
PE ratio (TTM) | 0.01 |
EPS (TTM) | 2.9670 |
Earnings date | 06 Nov 2023 - 10 Nov 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Shares of Emergent (EBS) are on a downward trajectory since the ticker was dropped from the S&P SmallCap 600 index.
Shares of Emergent BioSolutions (NYSE: EBS) were tumbling 10.6% lower as of 11:29 a.m. ET on Tuesday. The decline came after S&P Global's S&P Dow Jones Indices announced that Advance Auto Parts will replace Emergent BioSolutions in the S&P SmallCap 600 index. S&P Dow Jones Indices said that the change will be effective before the market opens on Friday, Aug. 25.